Obtaining a specific OPS-code for an innovative medical technology at an early stage is considered an important milestone in a dominant and successful Reimbursement & Market Access strategy.
For this purpose, it is necessary to submit a proposal to the Federal Institute for Drugs and Medical Devices (BfArM) by the end of February. The prequalifying and expert support of relevant medical societies is desirable and cannot be requested early enough.
Read more about OPS-codes, about market access in Germany, about Healthcare Heads or contact us directly.
E-Mail: info@healthcareheads.com
Phone: +49 431 800 147 0